AI assistant
Inotiv, Inc. — Earnings Release 2004
Feb 17, 2004
34595_rns_2004-02-17_8e878e00-4476-4269-959b-faa1063ba030.zip
Earnings Release
Open in viewerOpens in your device viewer
8-K 1 bas8kfeb12.htm BIOANALYTICAL 8K Bioanalytical Systems, Inc. - Form 8K (dated 10/31/2003
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 12, 2004
BIOANALYTICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter)
| Indiana | 0-23357 | 35-1345024 |
|---|---|---|
| (State or other jurisdiction of incorporation or organization) | (Commission File Number) | (IRS Employer Identification No.) |
| 2701 Kent Avenue West Lafayette, Indiana | 47906-1382 | |
| (Address of principal executive offices) | (Zip Code) | |
| (765) 463-4527 | ||
| (Registrant's telephone number, including area code) |
Item 12. Results of Operations and Financial Condition
On February 12, 2004, Bioanalytical Systems, Inc. issued a press release providing information on earnings and other financial results for its first quarter of fiscal 2004 ended December 31, 2003. The full text of the press release is furnished as Exhibit 99.1 to this Form 8-K.
The information in this Form 8-K is being furnished and shall not be deemed "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Form 8-K shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
MARKER FORMAT-SHEET="Head Major Center Bold" FSL="Workstation"
SIGNATURES
MARKER FORMAT-SHEET="Para Indent Lv 0-TNR" FSL="Default"
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: February 16, 2004 Bioanalytical Systems, Inc. By: /s/ Michael P. Silvon Michael P. Silvon Chief Financial Officer (Interim)
MARKER FORMAT-SHEET="Head Major Center Bold 1" FSL="Default"
Exhibit Index
Exhibit No. Description
99.1 Bioanalytical Systems, Inc. press release, issued February 12, 2004.